￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Another country won: Lumakras® was approved in Japan for the treatment of KRAS G12C mutant advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
The emerging anti-cancer all-rounder-ramucirumab

2025-10-19 11:44:20

Check Details
Tepotinib hydrochloride tablets have been approved for marketing for the treatment of non-small cell lung cancer!

2025-10-19 11:44:20

Check Details
How effective is the new drug apalutamide for treating prostate cancer? Are there any side effects?

2025-10-19 11:44:20

Check Details
European Commission approves lorlatinib as first-line treatment for ALK-positive advanced lung cancer_Canghule

2025-10-19 11:44:20

Check Details
What is the domestic price of icotinib? Where can I get cheap Icotinib

2025-10-19 11:44:20

Check Details
Capmatinib, a new drug with METex14 mutations in lung cancer, was approved for marketing!

2025-10-19 11:44:20

Check Details
What are the uses and side effects of capmatinib?

2025-10-19 11:44:20

Check Details
It can be called a miracle medicine! Larotinib, a targeted drug for lung cancer, improves patient survival by 6 times!

2025-10-19 11:44:20

Check Details
How much does larotrectinib cost? Can I buy it in Ningxia?

2025-10-19 11:44:20

Check Details
Neoadjuvant immunotherapy - an effective and safe treatment option for lung cancer patients

2025-10-19 11:44:20

Check Details
A new drug targeting ALK gene fusion mutations in lung cancer—ceritinib (Xanda)

2025-10-19 11:44:20

Check Details
Category
相关知识